Back to MW MARSHALL WACE, LLP

BCYCBCYC
Showing 5 of 17 quarters

Position history for MWMARSHALL WACE, LLP's holdings in BICYCLE THERAPEUTICS PLC

MARSHALL WACE, LLP holds 797,940 shares of BCYC (BICYCLE THERAPEUTICS PLC), worth $3.4M as of 2026-Q2. The position was increased (+111.5% shares). BCYC represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$3.4M

Current Shares

797,940

Total Value Change

-$4.1M

Total Shares Change

+467,682

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
797,940
+111.5%
$3.4M0.0%$4.24
43
2026-Q1
Increased
377,335
+872.6%
$1.8M0.0%$5.50
42
2025-Q4
New
38,795
-
$274,6690.0%$6.80
32
2024-Q4
Exited
0
-100.0%
$00.0%$14.13
0
2024-Q3
Increased
330,258
+271.1%
$7.5M0.0%$23.21
44

Other major holders of BCYC: BAKER BROS. ADVISORS LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used